The State of the Fertility Field

For each category in sector, coming January 2026


BY INSIDE REPRODUCTIVE HEALTH

The "State of the Fertility Field" is coming together as a category series covering 16 primary categories in the fertility sector. These category overviews lay the foundation for the business intelligence platform fertility professionals need.

Each of the overviews are resources delivered to decision-makers who evaluate and purchase solutions within each category, from AI platforms to pharmaceutical products.

Each report covers market dynamics, innovation trends, buyer priorities, and competitive positioning. Early sponsors including but not limited to Vitrolife, CCRM, Pinnacle Fertility, Cercle, Cycle Clarity, Future Fertility, and Unify Inc will have increased visibility in the overviews of their respective categories.


Was Your Company Left Out?

Standard Pricing Ends Soon

  • 40+ companies have already secured enhanced visibility to their target decision-makers

  • If you don't see your company's name in the category lists above, your competitors are getting the advantage

  • Every month you wait costs $300+ more - and your competitors lock in lower pricing

  • 7,000 unique fertility professionals read and listen to Inside Reproductive Health every year

  • Category "State of" reports will give sponsors increased visibility

  • Your customers, prospects, and investors will see these reports - with or without you

  • Standard pricing ends soon

If your leadership team isn't seeing this, forward it now before your competitors secure all the positioning advantage.


Which Companies Will Reach Which Decision-Makers

State of Artificial Intelligence

  • BAIBYS, Cercle, Cycle Clarity, Future Fertility, Unify Inc and others will receive enhanced visibility to Medical Directors, IVF Lab Directors, Operations Directors, Chief Innovation Officers, Clinic Network CEOs

State of Clinical Operations Software

  • Artisan Medical Solutions, LEVY Health, MediTEX, Venna Health and others will receive enhanced visibility to Clinic Network COOs, Operations Directors, Practice Administrators, Practice Owners, Clinic Network CEOs

State of Cryostorage | Cryosafety

  • CryoFuture, ReproTech and others will receive enhanced visibility to Lab Directors, Medical Directors, Practice Owners, Senior Embryologists, Clinic Network CEOs

State of Devices and Equipment

  • Vitrolife, Samsung and others will receive enhanced visibility to Medical Directors, Lab Directors, REI Physicians, Operations Directors, Clinic Network COOs and Chief Medical Officers

State of Diagnostic Lab | At Home Testing

  • Fellow and others will receive enhanced visibility to Medical Directors, REI Physicians, Practice Directors, Operations Directors, Lab Directors

State of Fertility Clinic Network | MSO

  • CCRM Fertility, FutureLife Group, Kindbody, Piedmont Reproductive Endocrinology, Pinnacle Fertility, The Fertility Partners, Prelude/Inception and others will receive enhanced visibility to Independent Practice Owners, REI Fellows, prospective employees like physicians and embryologists, and prospective investors

State of Genetics | Genomics | Carrier Screening

  • GeneScreen and others will receive enhanced visibility to Medical Directors, REI Physicians, Lab Directors, Practice Directors, Clinic Network CEOs

State of Insurance | Employee Benefit Management

  • Practice Directors, Clinic Network CFOs, Operations Directors, Medical Directors, Clinic Network CEOs

State of Patient Concierge | Digital Clinic

  • Practice Directors, Operations Directors, Medical Directors, Practice Administrators, Clinic Network CEOs

State of Patient Finance

  • Future Family, PatientFi, Sunfish and others will receive enhanced visibility to Practice Directors, Clinic Network CFOs, Operations Directors, Practice Administrators, Clinic Network CEOs

State of Pharmaceuticals

  • Granata Bio, Meitheal Pharmaceuticals and others will receive enhanced visibility to Medical Directors, REI Physicians, Practice Directors, Nurse Practitioners, Physician Assistants

State of Pharmacy

  • Mandell's Clinical Pharmacy and others will receive enhanced visibility to Medical Directors, REI Physicians, Practice Directors, RN IVF/PGD Coordinators, Nurse Practitioners, Nurses and Nurse Managers

State of Professional Services

  • EVERSANA, Fertility Consultancy, MedTech 4 Solutions, Mind360, Nationwide IVF Service, and others will receive enhanced visibility to Practice Directors, Clinic Network CFOs, Operations Directors, Medical Directors, Clinic Network CEOs

State of Supplements

  • Bird&Be and others will receive enhanced visibility to Medical Directors, REI Physicians, Practice Directors, Nurse Practitioners, Operations Directors, Nurses and Nurse Managers

State of Third Party IVF Services

  • Medical Directors, Third Party Reproduction Directors, REI Physicians, Practice Directors, Clinic Network Chief Medical Officers and COOs

Timing: New Year, PCRS, ESHRE, ASRM

The “State of” category overviews will be published as long form news features twice per year;: slated for shortly after the New Year and roughly before the ESHRE annual meeting. Every category in the fertility space will be summarized by

  • Big picture

  • Market dynamics 

  • Innovation 

  • What buyers are prioritizing

  • Looking ahead

The long form news features will be complimented by podcast episodes in the alternating quarters of the year, slated for roughly before the PCRS and ASRM annual meetings. The podcast episodes will add color commentary to the overviews, like

  • Hot takes

  • Reading between the lines

  • Practical implications

  • Predictions

Market Intelligence 

Subsequent category overviews will gradually consolidate scattered vendor information into systematic analyses. They are meant to eventually replace the early stages of RFPs and vendor evaluations and cover pricing pressures, regulatory changes, and acquisition activity, comparable to what capital risk firms use for investment decisions. 

“You’ll notice we use the word eventually a lot," laughed Griffin Jones, founder of Inside Reproductive Health, pointing to Inside Reproductive Health’s organic growth as a zero-debt, independently owned firm. Jones says that because IRH has no obligations to outside investors, the size and growth-speed of their platform is commensurate with that of the fertility space

“Both the audience and sponsors know we’re not promising something revolutionary overnight. But they see the quality of information keeps getting better each time, and thus, the audience and their engagement keep growing”.

Distribution through Inside Reproductive Health's platform reaches over 7,000 fertility professionals annually, with category-specific targeting to relevant decision-makers.

Inside Reproductive Health’s database of all 500 companies in the fertility space will go live on their website on October 23, 2025 prior to the American Society for Reproductive Medicine (ASRM) congress.

Not all companies will be included in their category’s respective “State Of”  to the aforementioned decision makers. Companies who were mentioned in this article have already secured their sponsorship in the IVF Heroes Universe Those organizations who were not mentioned in this article can guarantee their visibility in their category’s “State Of”, but standard pricing ends September 30, 2025 . 


Was Your Company Left Out?

Standard Pricing Ends Soon

  • 40+ companies have already secured enhanced visibility to their target decision-makers

  • If you don't see your company's name in the category lists above, your competitors are getting the advantage

  • Every month you wait costs $300+ more - and your competitors lock in lower pricing

  • 7,000 unique fertility professionals read and listen to Inside Reproductive Health every year

  • Category "State of" reports will give sponsors increased visibility

  • Your customers, prospects, and investors will see these reports - with or without you

  • Standard pricing ends soon

If your leadership team isn't seeing this, forward it now before your competitors secure all the positioning advantage.